CV Sciences, Inc. is a life science company. The Company operates in two segments: specialty pharmaceuticals and consumer products. The Company's specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol (CBD) across several therapeutic areas. The consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CVSI As of 05/04/19
Order Online - https://pluscbdoil.com/
"With shares of CV Sciences Inc (OTCMKTS:CVSI) now potentially tracing out a bull flag consolidation following its recent symmetrical triangle bullish breakout, we would assume there are plenty of new eyes now surveying the stock. To further flesh out the story, the company just announced that it has appointed Deloitte & Touche LLP as the company’s new independent registered public accounting firm.
Naturally, this announcement comes on the heels of the company’s recent statement that, as of March 31, 2019 its PlusCBD Oil branded products have achieved a distribution footprint that includes a whopping 3,308 retail stores, which is up 48% from 2,238 retail stores as of the end of 2018." - James Hudson Oracle Dispatch
Promoted {{ article.headline | getDecodedUnicode }} • {{ article.symbol }} • {{ article.date }} {{ article.time }}